CRTX: Cortexyme Inc Stock

by  •  • Comments Off on CRTX: Cortexyme Inc Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,142.49
Enterprise Value ($M) 1,075.70
Book Value ($M) 172.26
Book Value / Share 5.83
Price / Book 6.24
NCAV ($M) 120.66
NCAV / Share 4.08
Price / NCAV 9.47

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.62
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 8.11

Balance Sheet (mrq) ($M)
Current Assets 137.86
Assets 189.47
Liabilities 17.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -78.89
Net Income -76.85
Earnings Per Share Basic And Diluted -2.63

Cash Flow Statement (mra) ($M)
Cash From Operations -50.82
Cash from Investing -52.43
Cash from Financing -52.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-25 13G/A Pfizer Inc 7.00 -4.06
03-10 13G/A Capital World Investors 10.70 21.47
02-16 13G Capital International Investors 8.70
02-16 13G/A Capital Research Global Investors 8.80 6.67
02-01 13G/A Epq Llc, Ctym Ps 9.71
01-29 13G/A Takeda Pharmaceutical Co Ltd 0.30 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-03-01 10-K Annual Report – 10-K
2020-11-12 10-Q Quarterly Report – 10-Q
2020-08-14 10-Q Quarterly Report – 10-Q
2020-05-12 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-04-13 91,950 268,967 34.19
2021-04-12 73,621 278,395 26.44

(click for more detail)

(click for list of largest short owners)

Similar Companies
CRNX – Crinetics Pharmaceuticals Inc CRON – Cronos Group Inc.
CRSP – Crispr Therapeutics AG CRVS – Corvus Pharmaceuticals Inc
CSBR – Champions Oncology Inc


Financial data and stock pages provided by
Fintel.io